raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:251899

Choroid plexus carcinoma

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Childhood
Status
active

Choroid plexus carcinoma is a rare and highly aggressive malignant type of choroid plexus tumor occurring almost exclusively in children, presenting with cerebrospinal fluid obstruction in the lateral ventricles (most common), the fourth and third ventricles or in multiple ventricles, leading to hydrocephalus and increased intracranial pressure, and manifesting with nausea, vomiting, abnormal eye movements, gait impairment, seizures and enlarged head circumference.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enChoroid plexus carcinoma
frCarcinome des plexus choroïdes
deChoroid-PlexuskarzinomPlexuskarzinom
esCarcinoma del plexo coroideo
itCarcinoma del plesso corioideo
nlCarcinoom van plexus choroideusPlexus choroideus-carcinoom
ptCarcinoma do plexo coróide
plRak splotu naczyniówkowego
csKarcinom choroidálního plexu
ukКарцинома судинного сплетіння
zh脉络丛癌
trKoroid pleksus karsinomu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM260500NTBTvalidated
ICD-10C71.7NTBTindexvalidated
ICD-112A00.22NTBTindexvalidated
ICD-11XH3M77Especificvalidated
MONDO0016718Evalidated
MeSHC562943Evalidated
UMLSC0431109Evalidated
GARD8238Evalidated
MedDRA10067478Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
TP53Disease-causing germline mutation(s) inAssessedHGNC:11998ENSG0000014151019117017p13.1tumor protein p5321445348[PMID]
5

Prevalence and incidence

3 records
TypeClassValueAreaQualificationValidationSource
Annual incidence<1 / 1 000 0000.01 / 100 000EuropeValue and classValidated2033323[PMID]_RARECARE surveillance of rare cancers in Europe[OTHER]
Point prevalence1-9 / 1 000 000—EuropeClass onlyValidated2033323[PMID]_RARECARE surveillance of rare cancers in Europe[OTHER]
Lifetime Prevalence1-9 / 1 000 0000.35 / 100 000EuropeValue and classValidated2033323[PMID]_RARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card